CRLBF Stock Chart & Stats
$0.76
>-$0.01(-1.12%)
At close: 4:00 PM EDT
$0.76
>-$0.01(-1.12%)
Day’s Range― - ―
52-Week Range$0.59 - $2.30
Previous CloseN/A
Volume71.30K
Average Volume (3M)524.35K
Market Cap
$332.48M
Enterprise Value$1.17K
Total Cash (Recent Filing)$32.87M
Total Debt (Recent Filing)$592.02M
Price to Earnings (P/E)―
Beta1.24
Next Earnings
Nov 05, 2026EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.29
Shares Outstanding355,588,680
10 Day Avg. Volume667,119
30 Day Avg. Volume524,350
Financial Highlights & Ratios
PEG Ratio-0.03
Price to Book (P/B)1.22
Price to Sales (P/S)0.62
P/FCF Ratio10.78
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$1.80Price Target Upside137.30% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.02
Revenue Forecast (FY)$479.75M
Bulls Say, Bears Say
Bulls Say
Operating ImprovementPositive EBIT and EBITDA indicate that Cresco’s core operations have improved, while a roughly 48% gross margin provides a foundation for operating leverage. If sustained, this progress can support reinvestment and gradually narrow the gap between operating performance and bottom-line profitability.
Integrated Market PositionOperating across cultivation, manufacturing, wholesale distribution, and owned retail gives Cresco multiple routes to reach customers and monetize its brands. This integrated model can improve control over product availability, merchandising, and channel mix as regulated state markets develop.
Positive Operating Cash FlowPositive trailing operating cash flow shows that the business is generating cash from ongoing operations despite its reported net loss. That provides some internal funding capacity and is an important base for improving financial resilience, provided cash conversion becomes more consistent over time.
Bears Say
Persistent Net LossesCresco remains materially unprofitable at the net-income level, limiting the earnings support available for reinvestment, debt reduction, and shareholder returns. Negative ROE also indicates that the existing capital base is not yet producing adequate bottom-line profits, weakening confidence in earnings durability.
Elevated LeverageHigh debt relative to equity reduces balance-sheet flexibility while the company is still working toward sustainable profitability. Declining equity can further magnify leverage, leaving less capacity to absorb operating setbacks or allocate cash toward growth and other strategic priorities.
Volatile Cash GenerationUneven free cash flow and the sharp year-over-year decline weaken confidence in Cresco’s ability to self-fund consistently. Although operating cash flow is positive, limited coverage of the net loss means the company may have less dependable capacity for investment, debt service, and balance-sheet repair.
Cresco Labs News
CRLBF FAQ
What was Cresco Labs’s price range in the past 12 months?
Cresco Labs lowest stock price was $0.59 and its highest was $2.30 in the past 12 months.
What is Cresco Labs’s market cap?
Cresco Labs’s market cap is $332.48M.
When is Cresco Labs’s upcoming earnings report date?
Cresco Labs’s upcoming earnings report date is Nov 05, 2026 which is in 40 days.
How were Cresco Labs’s earnings last quarter?
Cresco Labs released its earnings results on Aug 06, 2026. The company reported $0.04 earnings per share for the quarter, beating the consensus estimate of -$0.016 by $0.056.
Is Cresco Labs overvalued?
According to Wall Street analysts Cresco Labs’s price is currently Undervalued.
Does Cresco Labs pay dividends?
Cresco Labs does not currently pay dividends.
What is Cresco Labs’s EPS estimate?
Cresco Labs’s EPS estimate is -0.02.
How many shares outstanding does Cresco Labs have?
Cresco Labs has 355,588,680 shares outstanding.
What happened to Cresco Labs’s price movement after its last earnings report?
Cresco Labs reported an EPS of $0.04 in its last earnings report, beating expectations of -$0.016. Following the earnings report the stock price went up 9.589%.
Which hedge fund is a major shareholder of Cresco Labs?
Currently, no hedge funds are holding shares in CRLBF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cresco Labs Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$1.80 (137.30% Upside)
$1.80 (137.30% Upside)
Blogger Sentiment
Bullish
CRLBF Sentiment 67%
Sector Average 63%
Sector Average 63%
Insider Transactions
Sold Shares
Worth $146.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 0.8%
Last 30 Days ▲ 0.7%
Last 30 Days ▲ 0.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-27.23%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-6.27%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Cresco Labs
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes, gummies, and pre-rolls under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company offers cannabis flowers under the FloraCal brand; and cannabis oils and variety of bites are available at multiple potency levels under the Mindy’s brand, as well as Loud*r brand. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company is headquartered in Chicago, Illinois.
CRLBF Company Deck
CRLBF Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a cautiously optimistic outlook: management delivered solid Q1 margins and EBITDA from a streamlined cost structure, achieved meaningful operational and licensing wins (PA store expansion, Ohio openings, Kentucky harvest, Texas license) and provided constructive Q2 growth guidance (~+10% revenue). Offsets include near-term revenue headwinds from the planned California exit and Michigan excise tax, ongoing pricing compression, seasonal cash flow timing, and unresolved regulatory details around rescheduling (including the scope and timing of 280E relief). On balance, operational momentum, accretive M&A activity, and licensing progress outweigh the short-term market and regulatory challenges.View all CRLBF earnings summariesCRLBF Stock 12 Month Forecast
Average Price Target
$1.80
▲(137.30% Upside)